Greenwood Capital Associates’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-67,234
Closed -$523K 244
2024
Q4
$523K Sell
67,234
-12,099
-15% -$90.2K 0.07% 180
2024
Q3
$643K Buy
79,333
+45,488
+134% +$372K 0.08% 167
2024
Q2
$234K Buy
33,845
+2,598
+8% +$35K 0.03% 221
2024
Q1
$553K Sell
31,247
-539
-2% -$8.53K 0.07% 185
2023
Q4
$492K Sell
31,786
-1,108
-3% -$14.5K 0.06% 193
2023
Q3
$451K Sell
32,894
-214
-0.6% -$3.15K 0.07% 194
2023
Q2
$571K Sell
33,108
-319
-1% -$6.53K 0.08% 181
2023
Q1
$802K Sell
33,427
-3,845
-10% -$83.6K 0.12% 149
2022
Q4
$647K Buy
37,272
+1,431
+4% +$30.2K 0.11% 151
2022
Q3
$873K Sell
35,841
-777
-2% -$26.7K 0.15% 118
2022
Q2
$1.13M Buy
36,618
+97
+0.3% +$2.58K 0.18% 96
2022
Q1
$1.27M Buy
36,521
+7,652
+27% +$289K 0.34% 53
2021
Q4
$1.71M Buy
28,869
+16
+0.1% +$1.11K 0.24% 79
2021
Q3
$1.92M Buy
28,853
+1,392
+5% +$85.8K 0.29% 71
2021
Q2
$1.73M Buy
27,461
+406
+2% +$22.9K 0.26% 75
2021
Q1
$1.41M Sell
27,055
-2,209
-8% -$134K 0.22% 86
2020
Q4
$1.28M Buy
29,264
+1,771
+6% +$84.4K 0.22% 85
2020
Q3
$1.3M Sell
27,493
-2,927
-10% -$119K 0.25% 76
2020
Q2
$920K Buy
30,420
+2,897
+11% +$64.5K 0.21% 76
2020
Q1
$470K Sell
27,523
-5,091
-16% -$89.2K 0.14% 81
2019
Q4
$537K Buy
32,614
+13,046
+67% +$194K 0.11% 105
2019
Q3
$320K Sell
19,568
-446
-2% -$8.94K 0.08% 123
2019
Q2
$367K Buy
20,014
+1,100
+6% +$17.5K 0.09% 119
2019
Q1
$244K Sell
18,914
-517
-3% -$5.62K 0.06% 151
2018
Q4
$214K Buy
19,431
+4,613
+31% +$50.1K 0.06% 157
2018
Q3
$190K Buy
14,818
+4,497
+44% +$64.2K 0.04% 184
2018
Q2
$163K Buy
+10,321
New +$110K 0.04% 191

Other funds holding CYRX

Greenwood Capital Associates's CYRX Position: Q1 2025 in Review

Greenwood Capital Associates sold out of CryoPort (CYRX) in Q1 2025, closing a stake of 67,234 shares — an estimated $523K sold.

Greenwood Capital Associates first reported a position in CYRX in Q2 2018 and held it in 27 quarters. The position peaked at $1.92M in Q3 2021. 153 funds tracked by Wall St. Rank hold CYRX as of Q1 2025.

  • Greenwood Capital Associates reported no remaining CryoPort position as of Q1 2025 after selling out during the quarter.
  • Greenwood Capital Associates sold 67,234 CryoPort shares in Q1 2025, an estimated $523K.
  • Greenwood Capital Associates first reported a position in CryoPort in Q2 2018 and held it in 27 quarters.
  • Greenwood Capital Associates's CryoPort position peaked at $1.92M in Q3 2021.
  • 153 funds tracked by Wall St. Rank held CryoPort as of Q1 2025.

Based on Greenwood Capital Associates's 13F filing for Q1 2025, filed 15 Apr 2025.